Bevacizumab in HER2-negative inflammatory breast cancer - Aix-Marseille Université Access content directly
Journal Articles Oncoscience Year : 2016

Dates and versions

hal-03623723 , version 1 (29-03-2022)

Identifiers

Cite

François Bertucci, Anthony Goncalves, Patrice Viens. Bevacizumab in HER2-negative inflammatory breast cancer. Oncoscience, 2016, 3 (11-12), pp.297-298. ⟨10.18632/oncoscience.324⟩. ⟨hal-03623723⟩
7 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More